[HTML][HTML] PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade

Q Peng, X Qiu, Z Zhang, S Zhang, Y Zhang… - Nature …, 2020 - nature.com
Immune checkpoint blockade therapies have shown clinical promise in a variety of cancers,
but how tumor-infiltrating T cells are activated remains unclear. In this study, we explore the …

PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade

Q Peng, X Qiu, Z Zhang, S Zhang… - Nature …, 2020 - econpapers.repec.org
Immune checkpoint blockade therapies have shown clinical promise in a variety of cancers,
but how tumor-infiltrating T cells are activated remains unclear. In this study, we explore the …

[PDF][PDF] PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade

Q Peng, X Qiu, Z Zhang, S Zhang, Y Zhang, Y Liang… - researchgate.net
PD-L1 expression can be induced in many cells during inflammation responses. Our
previous study has shown that blocking PD-L1 on myeloid cells is important for the …

PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade.

Q Peng, X Qiu, Z Zhang, S Zhang, Y Zhang… - Nature …, 2020 - europepmc.org
Immune checkpoint blockade therapies have shown clinical promise in a variety of cancers,
but how tumor-infiltrating T cells are activated remains unclear. In this study, we explore the …

PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade

Q Peng, X Qiu, Z Zhang, S Zhang, Y Zhang… - Nature …, 2020 - ideas.repec.org
Immune checkpoint blockade therapies have shown clinical promise in a variety of cancers,
but how tumor-infiltrating T cells are activated remains unclear. In this study, we explore the …

PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade

Q Peng, X Qiu, Z Zhang, S Zhang, Y Zhang… - Nature …, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Immune checkpoint blockade therapies have
shown clinical promise in a variety of cancers, but how tumor-infiltrating T cells are activated …

[PDF][PDF] PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade

Q Peng, X Qiu, Z Zhang, S Zhang, Y Zhang, Y Liang… - scholar.archive.org
PD-L1 expression can be induced in many cells during inflammation responses. Our
previous study has shown that blocking PD-L1 on myeloid cells is important for the …

PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade

Q Peng, X Qiu, Z Zhang, S Zhang… - Nature …, 2020 - pubmed.ncbi.nlm.nih.gov
Immune checkpoint blockade therapies have shown clinical promise in a variety of cancers,
but how tumor-infiltrating T cells are activated remains unclear. In this study, we explore the …

PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade

Q Peng, X Qiu, Z Zhang, S Zhang… - Nature …, 2020 - utsouthwestern.elsevierpure.com
Immune checkpoint blockade therapies have shown clinical promise in a variety of cancers,
but how tumor-infiltrating T cells are activated remains unclear. In this study, we explore the …

[HTML][HTML] PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade

Q Peng, X Qiu, Z Zhang, S Zhang, Y Zhang… - Nature …, 2020 - ncbi.nlm.nih.gov
Immune checkpoint blockade therapies have shown clinical promise in a variety of cancers,
but how tumor-infiltrating T cells are activated remains unclear. In this study, we explore the …